Arcturus Therapeutics (ARCT) PT Lowered to $20 at BTIG

September 24, 2026 5:40 AM

BTIG analyst Thomas Shrader lowered the price target on Arcturus Therapeutics (NASDAQ: ARCT) to $20.00 (from $23.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found